The Use of Radiolabelled Compounds in the Investigation of Metabolism and Drug-Drug Interactions In Vitro
22 August 2014

The investigation of the metabolic characteristics of a drug candidate using in vitro methods provides much valuable information and through human in vitro in vivo extrapolation (IVIVE) allows the prediction of the drug’s metabolic behaviour and effect on other drugs in patients once administered clinically. The quality and hence utility of the data that are obtained from several in vitro studies is typically greatly enhanced by the use of a radiolabelled compound. Hence the initial financial outlay required to synthesise a radiolabelled analogue of the drug candidate should be seen as a judicious investment. The advantages that the use of a radiolabelled form of the drug candidate brings are considered in this publication.

Show    per page
1 of 2     Page  1 2 Next 
Overcoming Obstacles to Develop a Cancer Immunotherapeutic cancer cells, clinical study, gene therapy19 Aug 2014Read
7 Ways to Reduce Inflammation Study Challenges clinical study, inflammatory diseases5 Jun 2014Read
The Nut Thing - Oral Immunotherapy, a Personal Journey allergen2 Jun 2014Read
Bioenergetic Analysis of Suspension Cells: Hematopoietic Stem Cells and Lymphocytes immunoassay, assay development22 May 2014Read
Bioenergetic Analysis of Primary Neuronal Deficiencies cellular bioenergetics, synaptosomes, mitochondria21 May 2014Read
CAR mRNA Loaded Freshly Isolated Peripheral Blood Lymphocytes as Rapid, Targeted Tumor Immunotherapy cancer, transfection, lymphocytes19 May 2014Read
MALDI Imaging Success Stories in Clinical Research clinical study, pharmaceuticals8 May 2014Read
Identifying Products for Drug Development Programs pharmaceuticals15 Mar 2014Read
CMC for 505(b)(2) Applications pharmaceuticals10 Mar 2014Read
Understanding the 505(b)(2) Approval Pathway pharmaceuticals10 Mar 2014Read

Popular tags in SelectScience

Buying guides